Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:51 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | Nantahala Capital Management LLC | 3,068,031 9.9% | 2,229,497 (+265.88%) | View |
| 2024-02-14 4:05 pm Sale | 13G | SOLENO THERAPEUTICS INC PA SLNO | COMMODORE CAPITAL LP | 700,000 2.3% | -185,741 (-20.97%) | View |
| 2024-02-13 5:35 pm Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | JANUS HENDERSON GROUP PLC JHG | 2,523,897 8.3% | 1,064,197 (+72.91%) | View |
| 2024-02-07 08:01 am Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,826,814 5.99% | 499,814 (+37.66%) | View |
| 2023-10-23 4:20 pm Unchanged | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 3,074,542 10.1% | 0 (Unchanged) | View |
| 2023-10-16 4:30 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 2,893,615 9.99% | 1,326,368 (+84.63%) | View |
| 2023-10-12 4:30 pm Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,327,000 8.69% | 1,327,000 (New Position) | View |
| 2023-10-12 4:05 pm Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | COMMODORE CAPITAL LP | 885,741 6% | 885,741 (New Position) | View |
| 2023-10-11 4:30 pm Unchanged | 13D | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings L.P. | 8,418,093 30.5% | 0 (Unchanged) | View |
| 2023-10-10 4:30 pm Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | Fairmount Funds Management LLC | 950,000 6.2% | 950,000 (New Position) | View |
| 2023-10-06 11:45 am Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | JANUS HENDERSON GROUP PLC JHG | 1,459,700 10.1% | 1,459,700 (New Position) | View |
| 2023-10-05 5:09 pm Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | RA CAPITAL MANAGEMENT L.P. | 1,233,300 4.6% | 1,233,300 (New Position) | View |
| 2023-10-03 4:05 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 1,567,247 9.99% | 339,930 (+27.70%) | View |
| 2023-09-28 9:51 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 3,074,542 23.7% | 866,789 (+39.26%) | View |
| 2023-08-30 4:05 pm Purchase | 13G | SOLENO THERAPEUTICS INC NE SLNO | HIRSCHMAN ORIN | 498,610 4.9% | 76,121 (+18.02%) | View |
| 2023-08-18 4:15 pm Purchase | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group Inc. CG | 1,227,317 12.3% | 1,227,317 (New Position) | View |
| 2023-08-15 4:15 pm Unchanged | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 2,207,753 22.1% | 0 (Unchanged) | View |
| 2023-06-06 4:17 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 2,207,753 27% | 178,298 (+8.79%) | View |
| 2023-06-01 5:00 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings L.P. | 8,418,093 50.8% | 8,418,093 (New Position) | View |
| 2023-05-30 4:15 pm Purchase | 13D | SOLENO THERAPEUTICS INC PA SLNO | PERCEPTIVE ADVISORS LLC | 2,029,455 24.8% | 85,000 (+4.37%) | View |